1. 0142 Training in safe administration of intrathecal chemotherapy – is in situ simulation the answer?: A pilot study. (2nd November 2015) Authors: Prakash, Anoop; Farooq, Omer; Durairaj, Senthilkumar; Allsup, David; Purva, Makani Journal: BMJ simulation & technology enhanced learning Issue: Volume 1(2015)Supplement 2 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia. Issue 4 (8th October 2018) Authors: Johnson, Ben; Doak, Rachel; Allsup, David; Astwood, Emma; Evans, Gillian; Grimley, Charlotte; James, Beki; Myers, Bethan; Stokley, Simone; Thachil, Jecko; Wilde, Jonathan; Williams, Mike; Makris, Mike; Lowe, Gillian C.; Wallis, Yvonne; Daly, Martina E.; Morgan, Neil V. Journal: Research and practice in thrombosis and haemostasis Issue: Volume 2:Issue 4(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. Issue 1 (December 2016) Authors: Howard, Dena; Munir, Talha; Hockaday, Anna; Rawstron, Andy; Collett, Laura; Oughton, Jamie; Allsup, David; Bloor, Adrian; Phillips, David; Hillmen, Peter Journal: Trials Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study. (24th May 2021) Authors: Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia. (3rd June 2021) Authors: Molica, Stefano; Allsup, David; Gianfelici, Valentina; Levato, Luciano; Aiello, Vincenzo; Bailey, James; Polliack, Aaron Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 6(2021) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia. Issue 7 (7th June 2021) Authors: Khan, Sujoy; Durairaj, Senthilkumar; Phumphukhieo, Punyarat; Holding, Stephen; Allsup, David Journal: Leukemia & lymphoma Issue: Volume 62:Issue 7(2021) Page Start: 1786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention. Issue 4 (2nd May 2022) Authors: Khan, Sujoy; Molica, Stefano; Allsup, David Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗